PITUITARY GLAND Mortality in acromegaly reduced with multimodal therapy

被引：7

作者：

Biermasz, Nienke R. ^{[1
]}

机构：

[1] Leiden Univ, Med Ctr, Dept Endocrinol, Ctr Endocrine Tumors, NL-2300 RC Leiden, Netherlands

来源：

NATURE REVIEWS ENDOCRINOLOGY | 2014年 / 10卷 / 12期

关键词：

IGF-I; METAANALYSIS; SURVIVAL;

D O I：

10.1038/nrendo.2014.193

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

The treatment of patients with acromegaly has progressed to encompass multimodal strategies that can include selective transsphenoidal adenomectomy, radiotherapy and somatostatin analogues. As a result, disease control and survival of these patients has improved.

引用

页码：708 / 709

页数：2

共 10 条

[1] Determinants of survival in treated acromegaly in a single center: Predictive value of serial insulin-like growth factor I measurements [J].

Biermasz, NR ;

Dekker, FW ;

Pereira, AM ;

van Thiel, SW ;

Schutte, PJ ;

van Dulken, H ;

Romijn, JA ;

Roelfsema, F .

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2004, 89 (06) :2789-2796

[2] Comparison of the effects of primary somatostatin analogue therapy and pituitary adenomectomy on survival in patients with acromegaly: a retrospective cohort study [J].

Bogazzi, Fausto ;

Colao, Annamaria ;

Rossi, Giuseppe ;

Lombardi, Martina ;

Urbani, Claudio ;

Sardella, Chiara ;

Iannelli, Aldo ;

Scattina, Ilaria ;

Manetti, Luca ;

Del Sarto, Simone ;

Pivonello, Rosario ;

Grasso, Ludovica Francesca Stella ;

Lupi, Isabella ;

Auriemma, Renata Simona ;

Lombardi, Gaetano ;

Martino, Enio .

EUROPEAN JOURNAL OF ENDOCRINOLOGY, 2013, 169 (03) :367-376

[3] Meta-Analysis and Dose-Response Metaregression: Circulating Insulin-Like Growth Factor I (IGF-I) and Mortality [J].

Burgers, Anne Marij G. ;

Biermasz, Nienke R. ;

Schoones, Jan W. ;

Pereira, Alberto M. ;

Renehan, Andrew G. ;

Zwahlen, Marcel ;

Egger, Matthias ;

Dekkers, Olaf M. .

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2011, 96 (09) :2912-2920

[4] Mortality in acromegaly: A meta analysis [J].

Dekkers, O. M. ;

Biermasz, N. R. ;

Pereira, A. M. ;

Romijn, J. A. ;

Vandenbroucke, J. P. .

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2008, 93 (01) :61-67

[5] A meta-analysis of the effect of lowering serum levels of GH and IGF-I on mortality in acromegaly [J].

Holdaway, I. M. ;

Bolland, M. J. ;

Gamble, G. D. .

EUROPEAN JOURNAL OF ENDOCRINOLOGY, 2008, 159 (02) :89-95

[6] Guidelines for Acromegaly Management: An Update [J].

Melmed, S. ;

Colao, A. ;

Barkan, A. ;

Molitch, M. ;

Grossman, A. B. ;

Kleinberg, D. ;

Clemmons, D. ;

Chanson, P. ;

Laws, E. ;

Schlechte, J. ;

Vance, M. L. ;

Ho, K. ;

Giustina, A. .

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2009, 94 (05) :1509-1517

[7]

Mercado M., J CLIN ENDOCRINOL ME

[8] A Paradigm Shift in the Monitoring of Patients With Acromegaly: Last Available Growth Hormone May Overestimate Risk [J].

Sherlock, Mark ;

Reulen, Raoul C. ;

Aragon-Alonso, Aurora ;

Ayuk, John ;

Clayton, Richard N. ;

Sheppard, Michael C. ;

Hawkins, Michael M. ;

Bates, Andrew S. ;

Stewart, Paul M. .

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2014, 99 (02) :478-485

[9] Mortality in Patients with Pituitary Disease [J].

Sherlock, Mark ;

Ayuk, John ;

Tomlinson, Jeremy W. ;

Toogood, Andrew A. ;

Aragon-Alonso, Aurora ;

Sheppard, Michael C. ;

Bates, Andrew S. ;

Stewart, Paul M. .

ENDOCRINE REVIEWS, 2010, 31 (03) :301-342

[10] Long-term mortality after transsphenoidal surgery and adjunctive therapy for acromegaly [J].

Swearingen, B ;

Barker, FG ;

Katznelson, L ;

Biller, BMK ;

Grinspoon, S ;

Klibanski, A ;

Moayeri, N ;

Black, PMCL ;

Zervas, NT .

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1998, 83 (10) :3419-3426

← 1 →